A British nurse, Pauline Cafferkey, who is being treated for Ebola at London's Royal Free hospital, is in a critical but stable condition, reported Britain's health minister. The nurse contracted the disease while working as a volunteer with the charity 'Save the Children' in Kerry Town, not far from Sierra Leone's capital Freetown.
Health Minister Jeremy Hunt said, "As has been reported, Pauline's condition has deteriorated to a critical state although she stabilized yesterday and continues to receive the best possible care."
Ebola Virus Disease
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.
Advertisement
Doctors treating the Scottish nurse said that she would be treated with blood plasma from an Ebola survivor containing virus-fighting antibodies as well as an experimental anti-viral drug.
Experts will review the training, safety protocols, how protective equipment is used, and working practices of volunteers in the charity. The charity's Sierra Leone director Rob MacGillivray said, "Because of this very serious event we have put in an extraordinary review to ensure that we do everything, leave no stone unturned to, as far as possible, identify the source of this infection."
Source: Medindia
Source: Medindia
EU’s Ebola Coordinator Focused to Have More Medical Personnel on the Ground
Europe must send more specialized medical personnel to West Africa and help rebuild local health systems to help tackle the outbreak of Ebola.
Advertisement
 WHO Meets Targets to Reduce Ebola SpreadThe World Health Organization (WHO) has reported of having achieved the targets to reduce the spread of Ebola by isolating patients and burying bodies safely. | Advertisement
|
Ebola Outbreak Will End in 2015
Anthony Banbury, the outgoing head of the United Nations Ebola Emergency Response (UNMEER) has said that the disease will be ended in 2015.
Advertisement
Recommended Readings
Latest Tropical Disease News
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.